Leo Pharma and PellePharm collaborate to advance innovative therapies for rare skin diseases Nov. 22, 2018
Tremfya receives additional indication approval as first biologic agent for palmoplantar pustulosis Nov. 21, 2018
Novan presents preliminary phase II results for SB-206 as treatment of molluscum contagiosum Nov. 15, 2018
Promising interim results presented from phase IIa study of CTP-543 in patients with alopecia areata Nov. 13, 2018
Novel RORgammat inhibitors developed by Shionogi for treating Th17-mediated autoimmune diseases Nov. 12, 2018
Discovery and optimization of Aurora B-selective SYK inhibitors as topical agents for skin diseases Nov. 8, 2018
RSS